Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCL25 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | LST1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | GEMIN2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | NOS3 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | ABO | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | TULP3 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | MELTF | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | PRKCD | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | PKP3 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
mRNA | LGALS8 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |